Khattar Jack A.

President, CEO at SUPERNUS PHARMACEUTICALS, INC.

Sold, on record
$39.3M
Dollars the filings state
Form 4 sales
31
Latest Mar 13, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Sep 22 2025

    Sold 16,587 shares at $47.02 ($780k)

    Khattar Jack A., President, CEO

    10b5-1 planSold 1.5% of holdings ($53.6M position)1.1M shares left0.4x usual sizeFiling

  2. 2 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Sep 23 +1 day

    Sold 29,513 shares at $47.23 ($1.4M)

    Khattar Jack A., President, CEO

    10b5-1 planSold 2.5% of holdings ($55.3M position)1.1M shares left0.8x usual sizeFiling

  3. 3 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Sep 29 +6 days

    Sold 10,235 shares at $48.02 ($491k)

    Khattar Jack A., President, CEO

    10b5-1 planSold 0.9% of holdings ($55.4M position)1.1M shares left0.3x usual sizeFiling

  4. 4 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Sep 30 +1 day

    Sold 8,588 shares at $48.25 ($414k)

    Khattar Jack A., President, CEO

    10b5-1 planSold 0.7% of holdings ($55.8M position)1.1M shares left0.3x usual sizeFiling

  5. 5 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Oct 1 +1 day

    Sold 40,173 shares at $48.07 ($1.9M)

    Khattar Jack A., President, CEO

    10b5-1 planSold 3.3% of holdings ($57.7M position)1.2M shares left1.7x usual sizeFiling

  6. 6 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Oct 2 +1 day

    Sold 1,904 shares at $48.06 ($92k)

    Khattar Jack A., President, CEO

    10b5-1 planSold 0.2% of holdings ($55.9M position)1.2M shares left0.1x usual sizeFiling

  7. 7 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Oct 9 +7 days

    Sold 59,900 shares at $50.57 ($3M)

    Khattar Jack A., President, CEO

    10b5-1 planSold 4.7% of holdings ($64M position)1.2M shares left2.6x usual sizeFiling

  8. 8 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Mar 13 +155 days

    Sold 35,000 shares at $50.37 ($1.8M)

    Khattar Jack A., President, CEO

    10b5-1 planSold 3.5% of holdings ($50M position)958,100 shares left1.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (31)

Form 144 notices and Form 4 sales by Khattar Jack A.
Source
Mar 13, 2026SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale35,000$1.8M3.5%RoutineSEC
Oct 9, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale59,900$3M4.7%RoutineSEC
Oct 2, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale1,904$92k0.2%RoutineSEC
Oct 1, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale40,173$1.9M3.3%RoutineSEC
Sep 30, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale8,588$414k0.7%RoutineSEC
Sep 29, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale10,235$491k0.9%RoutineSEC
Sep 23, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale29,513$1.4M2.5%RoutineSEC
Sep 22, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale16,587$780k1.5%RoutineSEC
Sep 8, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale6,322$293k0.6%RoutineSEC
Sep 5, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale55,578$2.6M4.8%RoutineSEC
Aug 28, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale34,800$1.6M3.1%RoutineSEC
Aug 25, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale1,000$45k0.1%RoutineSEC
Aug 22, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale1,500$68k0.1%RoutineSEC
Aug 6, 2025SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale140,000$5.9M11.6%RoutineSEC
Nov 8, 2024SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale125,000$4.5M11.9%UnusualSEC
Nov 7, 2024SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale125,000$4.6M11.9%UnusualSEC
Feb 2, 2023SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale13,532$569k1.7%Plan not statedSEC
Feb 1, 2023SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale300$13k0.0%Plan not statedSEC
Jan 31, 2023SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale976$41k0.1%Plan not statedSEC
Jan 18, 2023SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale4,936$199k0.6%Plan not statedSEC
Jan 17, 2023SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale25,446$1M3.1%Plan not statedSEC
Dec 21, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale15,360$585k1.9%Plan not statedSEC
Nov 25, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale13,394$471k1.7%Plan not statedSEC
Nov 22, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale600$21k0.1%Plan not statedSEC
Nov 21, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale531$19k0.1%Plan not statedSEC
Nov 15, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale1,115$39k0.1%Plan not statedSEC
Aug 16, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale14,690$500k1.9%Plan not statedSEC
Aug 15, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale17,302$589k2.2%Plan not statedSEC
Aug 10, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale28,437$888k3.7%Plan not statedSEC
Aug 9, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale39,431$1.2M5.2%Plan not statedSEC
Aug 8, 2022SUPERNUS PHARMACEUTICALS, INC.President, CEOForm 4 sale117,907$3.7M14.4%Plan not statedSEC